Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype.
In patients with triple-negative breast cancer (TNBC), tumor-infiltrating lymphocytes (TILs) are associated with improved survival. Lehmann et al. identified 4 molecular subtypes of TNBC [basal-like (BL) 1, BL2, mesenchymal (M), and luminal androgen receptor (LAR)], and an immunomodulatory (IM) gene...
Main Authors: | Kenichi Harano, Ying Wang, Bora Lim, Robert S Seitz, Stephan W Morris, Daniel B Bailey, David R Hout, Rachel L Skelton, Brian Z Ring, Hiroko Masuda, Arvind U K Rao, Steven Van Laere, Francois Bertucci, Wendy A Woodward, James M Reuben, Savitri Krishnamurthy, Naoto T Ueno |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6193579?pdf=render |
Similar Items
-
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
by: Toshiaki Iwase, et al.
Published: (2020-05-01) -
Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype.
by: Yohei Funakoshi, et al.
Published: (2019-01-01) -
Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research.
by: Jose Rodrigo Espinosa Fernandez, et al.
Published: (2020-01-01) -
Novel therapeutic strategies in the treatment of triple-negative breast cancer
by: Karima Oualla, et al.
Published: (2017-07-01) -
Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion
by: Emilly S. Villodre, et al.
Published: (2021-10-01)